The global invasive ductal carcinoma treatment market size was valued at USD 9.32 billion in 2024 and is projected to reach USD 15.21 billion by 2030, growing at a CAGR of 8.50% from 2025 to 2030. This growth is being driven by several key factors, including the rising prevalence of breast cancer worldwide, continuous technological advancements in medical treatments, an increasing...